|
Volumn 3, Issue 9, 2001, Pages 644-648
|
Amelioration of experimental colitis by thalidomide
a a a a a a a a |
Author keywords
Inflammatory bowel disease; Thalidomide; Tumor necrosis factor
|
Indexed keywords
CLONING;
ORGANIC COMPOUNDS;
PATIENT TREATMENT;
TUMORS;
COLITIS;
BIOMEDICAL ENGINEERING;
AUTACOID;
HYPNOTIC AGENT;
IODOACETAMIDE;
MYELOPEROXIDASE;
THALIDOMIDE;
TUMOR NECROSIS FACTOR ALPHA;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
COLITIS;
COLON;
COLON MUCOSA;
CONTROLLED STUDY;
CROHN DISEASE;
CYTOKINE PRODUCTION;
DOSE RESPONSE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG INHIBITION;
DRUG MECHANISM;
ENZYME ACTIVITY;
FEEDING;
HISTOLOGY;
MALE;
NONHUMAN;
ORGAN WEIGHT;
PROTEIN BLOOD LEVEL;
RAT;
ALKYLATING AGENTS;
ANIMALS;
COLITIS;
IMMUNOSUPPRESSIVE AGENTS;
IODOACETAMIDE;
RATS;
THALIDOMIDE;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0035670641
PISSN: 15651088
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (9)
|
References (25)
|